全文获取类型
收费全文 | 71569篇 |
免费 | 5513篇 |
国内免费 | 223篇 |
专业分类
耳鼻咽喉 | 864篇 |
儿科学 | 1617篇 |
妇产科学 | 1021篇 |
基础医学 | 9388篇 |
口腔科学 | 1089篇 |
临床医学 | 7706篇 |
内科学 | 15310篇 |
皮肤病学 | 898篇 |
神经病学 | 7106篇 |
特种医学 | 2455篇 |
外国民族医学 | 5篇 |
外科学 | 12530篇 |
综合类 | 830篇 |
一般理论 | 55篇 |
预防医学 | 5227篇 |
眼科学 | 1377篇 |
药学 | 4943篇 |
中国医学 | 86篇 |
肿瘤学 | 4798篇 |
出版年
2023年 | 533篇 |
2022年 | 905篇 |
2021年 | 2097篇 |
2020年 | 1263篇 |
2019年 | 1892篇 |
2018年 | 2301篇 |
2017年 | 1619篇 |
2016年 | 1707篇 |
2015年 | 1989篇 |
2014年 | 2879篇 |
2013年 | 3609篇 |
2012年 | 5575篇 |
2011年 | 5791篇 |
2010年 | 3117篇 |
2009年 | 2855篇 |
2008年 | 4699篇 |
2007年 | 4801篇 |
2006年 | 4610篇 |
2005年 | 4398篇 |
2004年 | 3944篇 |
2003年 | 3785篇 |
2002年 | 3455篇 |
2001年 | 728篇 |
2000年 | 610篇 |
1999年 | 641篇 |
1998年 | 730篇 |
1997年 | 558篇 |
1996年 | 461篇 |
1995年 | 401篇 |
1994年 | 371篇 |
1993年 | 353篇 |
1992年 | 386篇 |
1991年 | 355篇 |
1990年 | 311篇 |
1989年 | 291篇 |
1988年 | 270篇 |
1987年 | 266篇 |
1986年 | 245篇 |
1985年 | 246篇 |
1984年 | 242篇 |
1983年 | 188篇 |
1982年 | 162篇 |
1981年 | 149篇 |
1980年 | 167篇 |
1979年 | 122篇 |
1978年 | 107篇 |
1977年 | 104篇 |
1975年 | 91篇 |
1974年 | 92篇 |
1973年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
B. A. Johnson Donald R. Jasinski Gantt P. Galloway Henry Kranzler Robert Weinreib Raymond F. Anton Barbara J. Mason Michael J. Bohn Helen M. Pettinati Richard Rawson Christopher Clyde 《Psychopharmacology》1996,128(2):206-215
Four hundred and twenty-three alcohol dependent subjects were enrolled into a 12-week randomized, double-blind, placebo-controlled
study to determine the safety and efficacy of the 5-HT2 receptor antagonist, ritanserin (2.5 mg/day or 5 mg/day), in reducing alcohol intake and craving. All subjects received 1
week of single-blind placebo prior to randomization into the 11-week double-blind phase. Additionally, all subjects received
weekly individual sessions of manual-guided cognitive-behavioral therapy. Comparing the single-blind period with endpoint,
there was approximately a 23% reduction in drinks/day; 34% fall in the total number of drinking days/week; 22% decrease in
drinks/drinking day; and a 37% diminution in alcohol craving for all treatment groups. All treatment groups experienced a
beneficial clinical outcome as assessed by the Clinical Global Impression Scale. There was, however, no significant difference
between treatment groups on any of these measures of alcohol drinking, craving, or clinical outcome. Subjects were of relatively
high social functioning at baseline, and this did not change significantly during treatment. Treatment groups did not differ
significantly on either medication compliance or reported adverse events. Ritanserin treatment was associated with a dose-related
prolongation of subjects’ QTc interval recording on the electrocardiogram. These results suggest that alcohol dependent subjects
can show marked clinical improvement within a structured alcohol treatment program. These findings do not support an important
role for ritanserin in the treatment of alcohol dependence.
Received: 30 April 1996/Final version: 3 July 1996 相似文献
62.
Firouzan Massoomi Pharm.D. John Savage Pharm.D. Christopher J. Destache Pharm.D. 《Pharmacotherapy》1993,13(1):46-59
Omeprazole is a member of a new class of substituted benzimidazoles. These agents inhibit the proton pump in the gastric parietal cell, blocking the final step in the gastric acid secretory pathway. Omeprazole has been investigated for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux, and various hypersecretory states. The prolonged inhibition of gastric acid secretion allows for once-daily dosing in patients with peptic ulcer disease and gastroesophageal reflux, and once- or twice-daily dosing in patients with Zollinger-Ellison syndrome. Compared with currently available therapies, omeprazole is well tolerated and demonstrates a more rapid ulcer healing rate. It is superior to conventional therapies in the treatment of Zollinger-Ellison syndrome. Side effects are infrequent when the drug is used for the short-term management of ulcers. 相似文献
63.
Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen-containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effectiveparalysis. © 1993 John Wiley & Sons, Inc. 相似文献
64.
65.
Barbara A. Bresnahan Christopher P. Johnson Matthew J. McIntosh Donald Stablein Sundaram Hariharan 《American journal of transplantation》2002,2(4):366-372
The optimal allocation of cadaveric kidneys for transplantation with reference to human leukocyte antigen (HLA) match and sharing these organs to a distant center remains controversial. The current analysis was performed using the United Network for Organ Sharing (UNOS) database for cadaveric kidney transplants (Tx) between 1988 and 1997. The graft survivals of zero-mismatch (matched) kidneys with the mate (mismatched) kidneys were compared. There were 2385 donors and 4770 Tx. Significant differences in recipient demographics between matched and mismatched Tx were: fewer African-American race (AA) in the matched group (9.0% vs. 21.9%), higher number of previous Tx (25.5% vs. 14.8%) and elevated mean cold ischemia time (24.0 vs. 22.2 h). Post-Tx dialysis requirements were similar (22.8% vs. 24.1%, p = 0.62) and matched kidneys had to travel more distance (920 vs. 232 miles). Using a Cox model, the matched group had a decreased relative hazard of graft failure of 23.0% (p = 0.0002) or 35% (p < 0.0001) with and without censoring for death. There was significantly better graft survival in the matched recipients in all pairs except AA (matched) and non-AA (mismatched). For older donors (> or = 50 years, n = 1508), the matched grafts survival was marginally significant (p =0.05). Matched kidneys have improved survival compared with the mismatched kidneys despite the longer distance traveled. The benefit of mismatched transplants was predominantly seen in non-AA. 相似文献
66.
67.
Christopher Gillberg 《Journal of autism and developmental disorders》1991,21(1):61-77
Autism is associated with epilepsy. One third of the population of people with autism have developed seizures in early adult life. In spite of this well-known association, little is known about the treatment of epilepsy in autism. This paper reviews the sparse literature and reports a systematic case-record study of the treatment of epilepsy in autism. Some practical guidelines for clinicians are provided. Research in the field of epilepsy in autism is highly warranted.This study has been supported by a grant from The Commission for Social Research, Sweden, No. E 88/170:2. 相似文献
68.
Joshua E. Lane MD Christopher M. Peterson MD John L. Ratz MD 《Dermatologic surgery》2002,28(7):617-618
BACKGROUND: Pearly penile papules are angiofibromas found on the corona and sulcus of the glans penis. While these represent a benign condition, psychological and cosmetic concerns often prompt patients to seek therapeutic removal of these lesions. Multiple therapeutic modalities have been reported; however, use of CO2 laser has proven to be the most effective to date. OBJECTIVE: To demonstrate the efficacy of CO2 laser in treating pearly penile papules. METHODS: Case report. RESULTS: We report the successful treatment of pearly penile papules in an African American man with CO2 laser. CONCLUSION: The use of CO2 laser is an effective treatment for pearly penile papules. J. E. Lane, MD, C. M. Peterson, MD, and J. L. Ratz, MD have indicated no significant interest with commercial supporters. 相似文献
69.
P Tugwell L Hart G Kraag A Park C Dok F Bianchi C Goldsmith W W Buchanan 《The Journal of rheumatology》1984,11(4):457-461
A crossover double-blind controlled trial was performed on 36 patients with rheumatoid arthritis to assess the necessity for serum salicylate monitoring in determining optimal dosage. There was no clinically or statistically significant increase in the clinical improvement of patients associated with serum monitoring but potentially toxic serum levels occurred without tinnitus when serum monitoring was not used. 相似文献
70.